8:45am ET
Investing
Huge Insider Buying in MGM and Salesforce
As the year winds down, insiders make huge buys in MGM Resorts and Salesforce. However, those were not the only notable instances of insider buying seen recently.
Companies
/Healthcare
Zenas BioPharma, Inc. Common Stock
$33.04
▼ $0.73 (−2.16%) today
Markets closed · 9:12pm ET
Today · % change
Fundamentals
Market Cap
$2.2B
Revenue (TTM)
$1.0M
EPS (TTM)
$-10.27
52-Week Range
$14 – $45
Street Target
$47.00
About Zenas BioPharma
Zenas BioPharma, Inc. is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, specializing in the development and commercialization of innovative immunotherapy solutions. The company is committed to addressing significant unmet medical needs, particularly in the fields of autoimmune and rare diseases, and has established a promising pipeline of therapies powered by its proprietary technology platforms. By focusing on enhancing immune responses, Zenas aims to improve patient outcomes and strengthen its position as a leader in the biopharmaceutical industry.
